Latest Kidney transplantation Stories
LAWRENCE, Mass., Oct. 12, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, will participate in the National Kidney Foundation (NKF) New York City Kidney Walk with an on-site patient education tent and a team of company walking volunteers joined by Pitbull's recording artist David RUSH, a former NxStage® System One(TM) patient. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) The National Kidney...
Only Pediatric Program in New England to Receive Award BOSTON, Oct. 5, 2012 /PRNewswire-USNewswire/ -- The Department of Health and Human Services has recognized Boston Children's Hospital's Kidney Transplant Program as a national leader in its field. The program received a Silver Level Award at a Medal of Honor Ceremony held yesterday at the Seventh National Learning Congress in Grapevine, Texas. Awards were granted by the Health Resources and Services Administration's Donation and...
HORSHOLM, Denmark, Oct. 5, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that it has entered into an exclusive distribution agreement with Chiesi Farmaceutici S.p.A, a fully integrated European Pharmaceutical company focused on respiratory disease and special care products, for the commercialization and distribution of its novel formulation immunosuppressant drug candidate LCP-Tacro in certain countries, including Europe, Turkey and CIS countries....
DENVER, Oct. 4, 2012 /PRNewswire/ -- The U.S. Department of Health and Human Services (HHS) today awarded ten Colorado and Wyoming hospitals, three local transplant centers, as well as the organ procurement organization serving the same region with Medals of Honor for their success in maximizing the lifesaving gift of organ donation. The awards were presented today at the seventh annual National Learning Congress for the Donation and Transplantation Community of Practice held in...
WINSTON-SALEM, N.C., Oct. 3, 2012 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the pricing of a private placement of $15.0 million aggregate principal amount of Senior Secured Convertible Notes (the "Notes"), with certain investors, including Celgene Corporation, RA Capital Management LLC, Deerfield Management Company, LP, Bay City Capital and HealthCap. The $15.0 million principal amount includes the exchange of approximately...
Study found no evidence that lower-income individuals would be exploited Most Canadians view financial incentives for deceased kidney donation to be acceptable, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). Nearly half of the general public in Canada also find it acceptable for living kidney donation. Studies are now needed to determine whether acceptability of financial incentives translates to more available...
Event Honors Patients and Caregivers, Celebrating the People Who Inspire Us in the Fight Against Kidney Disease WASHINGTON, Sept. 27, 2012 /PRNewswire-USNewswire/ -- The American Kidney Fund's fourth annual national gala, The Hope Affair, will take place Wednesday, October 17, 2012, at 6:30 p.m. at the Andrew W. Mellon Auditorium in Washington, D.C. The event, themed "All Things Are Possible," will honor three remarkable individuals: a dialysis patient, a caregiver and the American...
Two new studies from the Johns Hopkins Bloomberg School of Public Health and the Chronic Kidney Disease Prognosis Consortium found that the presence of chronic kidney disease itself can be a strong indicator of the risk of death and end-stage renal disease (ESRD) even in patients without hypertension or diabetes. Both hypertension and diabetes are common conditions with chronic kidney disease with hypertension being the most prevalent. The studies were released online in advance of...
NORTHBROOK, Ill., Sept. 24, 2012 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for tacrolimus extended release capsules for the prophylaxis of organ rejection in adult kidney transplant recipients and adult male liver transplant recipients. Developed by Astellas,...
WASHINGTON, Sept. 21, 2012 /PRNewswire-USNewswire/ -- The George Washington University Hospital today announced that it will launch The GW Kidney Transplant Institute in 2013. "The establishment of a kidney transplant program is another step in the continued growth and development of GW Hospital," says Barry A. Wolfman, CEO and Managing Director of The George Washington University Hospital. "We believe GW Hospital is uniquely positioned to provide the comprehensive care and...
Latest Kidney transplantation Reference Libraries
The BK virus, a member of the polyomavirus family, has no major consequences of infected except with those that are immunocomprimised or immunosuppressed. The virus was first isolated in 1971 from the urine sample of a renal transplant patient whose initials were B.K. Similar in genome sequences to the JCV virus they are most easily identified and differentiated from each other through serological tests using specific antibodies or through PCR based genotyping approach. Most people are...
